JUPARIB 150MG (OLAPARIB)

JUPARIB 150MG (OLAPARIB)

Compare

Description

Juparib
Olaparib
150 mg

Composition:
Juparib 100 Tablet: Each flim coated tablet contains Olaparib INN 100 mg.
Juparib 150 Tablet: Each flim coated tablet contains Olaparib INN 150 mg.

Description:
Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA repair. Olaparib has been shown to inhibit growth of select tumor cell lines in vitro and decrease tumor growth in mouse xenograft models of human cancer both as monotherapy or following platinum-based chemotherapy. Increased cytotoxicity and anti-tumor activity following treatment with Olaparib were noted in cell lines and mouse tumor models with deficiencies in BRCA. In vitro studies have shown that Olaparib-induced cytotoxicity may involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complex, resulting in disruption of cellular homeostasis and cell death.

Indications:
Breast Cancer
Juparib is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor (HR)-positive breast cancer should have progressed on or be considered inappropriate for endocrine therapy. Germline BRCA mutation must be confirmed before Juparib treatment is initiated.

Ovarian Cancer
Juparib is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed (PSR) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete response or partial response) to platinumbased chemotherapy.

Manufactured by:
Julphar Bangladesh Ltd.

Reviews

There are no reviews yet.

Be the first to review “JUPARIB 150MG (OLAPARIB)”

Your email address will not be published. Required fields are marked *

X